Skip to main content
Anesthesiology Research and Practice logoLink to Anesthesiology Research and Practice
. 2017 Oct 17;2017:1368514. doi: 10.1155/2017/1368514

Corrigendum to “Sugammadex-Enhanced Neuronal Apoptosis following Neonatal Sevoflurane Exposure in Mice”

Maiko Satomoto 1,, Zhongliang Sun 1, Yushi U Adachi 2, Koshi Makita 1
PMCID: PMC5664264  PMID: 29181024

In the article titled “Sugammadex-Enhanced Neuronal Apoptosis following Neonatal Sevoflurane Exposure in Mice” [1], the concentration of sugammadex injected into the mice, 30 mg/kg, was incorrect; the correct concentration is 300 mg/kg. The undiluted sugammadex concentration was 100 mg/ml and not 10 mg/ml. Accordingly, in the section “Sugammadex Treatment,” the statement “with a single 30 mg/kg dose” should be corrected to “with a single 300 mg/kg dose” and, in the Discussion section, the statement “we chose 30 mg/kg” should be corrected to “In this study, we chose 300 mg/kg.”

References

  • 1.Satomoto M., Sun Z., Adachi Y. U., Makita K. Sugammadex-enhanced neuronal apoptosis following neonatal sevoflurane exposure in mice. Anesthesiology Research and Practice. 2016;2016:1–6. doi: 10.1155/2016/9682703.9682703 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Anesthesiology Research and Practice are provided here courtesy of Wiley

RESOURCES